Article
Transition to androgen-independence in prostate cancer.
The Journal of steroid biochemistry and molecular biology - 1 Jul 2002
Navarro Domingo, Luzardo Octavio P, Fernández Leandro, Chesa Nicolás, Díaz-Chico Bonifacio N
Abstract excerpt
Prostate carcinoma is the most frequently diagnosed malignancy and the second leading cause of death as a result of cancer in men in the western countries. Withdrawal of androgens or the peripheral blockage of androgen action remain the critical therapeutic options for the treatment of advanced prostate cancer. However, after initial regression, most of the prostate cancers become androgen-independent and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
